Company intelligence / Profile preview

RxGenomix

United States

Ownership: Private
Development stage: Other

Overview

RxGenomix operates as a commercial pharmacogenomics service and clinical decision support provider. It offers the ExactMeds pharmacogenomic service, which uses genotyping from saliva samples to generate medication risk reports, and the RxGenomix Hub, an interoperable clinical decision support and workflow platform connecting pharmacies, prescribers and labs. It focuses on improving prescribing, reducing adverse drug events and healthcare costs, and does not itself run drug-development clinical trials.[1][2][5]

Therapeutic areas: PsychiatryCardiovascularOther
Modalities: Non-pharmacological therapyDevice
Industry: Molecular Diagnostics

Partnerships

Translational Software (pharmacogenomics interpretation and clinical decision support partnership)[3][7]

Beyond the preview

Go deeper on RxGenomix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RxGenomix.

Explore the full profile